SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Statistical Methods in Medical Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Thompson, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thompson, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Controversies in meta-analysis: the case of the trials of serum cholesterol reduction

SG Thompson

London School of Hygiene and Tropical Medicine, London

There has recently been disagreement in the literature on the results and interpretation of meta-analyses of the trials of serum cholesterol reduction, both in terms of the quantification of the effect on ischaemic heart disease and as regards the evidence of any adverse effect on other causes of death. This paper describes statistical aspects of a recent meta-analysis of these trials, and draws some more general conclusions about the methods used in meta-analysis. Tests of an overall null hypothesis are shown to have a basis clearly distinct from the more extensive assumptions needed to provide an overall estimate of effect. The fixed effect approach to estimation relies on the implausible assumption of homogeneity of treatment effects across the trials, and is therefore likely to yield confidence intervals which are too narrow and conclusions which are too dogmatic. However the conventional random effects method relies on its own set of unrealistic assumptions, and cannot be regarded as a robust solution to the problem of statistical heterogeneity. The random effects method is more usefully regarded as a type of sensitivity analysis in which the weights allocated to each study in estimating the overall effect are modified. However, rather than using a statistical model for the 'unexplained' heterogeneity, greater insight and scientific understanding of the results of a set of trials may be obtained by a careful exploration of potential sources of heterogeneity. In the context of the cholesterol trials, the heterogeneity according to the extent and duration of cholesterol reduction are of prime concern and are investigated using logistic regression. It is concluded that the long-term benefits of serum cholesterol reduction on the risk of heart disease have been seriously underestimated in some previous meta-analyses, while the evidence for adverse effects on other causes of death have been misleadingly exaggerated.

Statistical Methods in Medical Research, Vol. 2, No. 2, 173-192 (1993)
DOI: 10.1177/096228029300200205


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. R. Crouse III, R. P. Byington, H. M. Hoen, and C. D. Furberg
Reductase Inhibitor Monotherapy and Stroke Prevention
Arch Intern Med, June 23, 1997; 157(12): 1305 - 1310.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
T. C. Keyserling, A. S. Ammerman, C. E. Davis, M. C. Mok, J. Garrett, and R. Simpson Jr
A Randomized Controlled Trial of a Physician-Directed Treatment Program for Low-Income Patients With High Blood Cholesterol: The Southeast Cholesterol Project
Arch Fam Med, March 1, 1997; 6(2): 135 - 145.
[Abstract] [PDF]


Home page
JAMAHome page
J. C. Cappelleri, J. P. A. loannidis, C. H. Schmid, S. D. de Ferranti, M. Aubert, T. C. Chalmers, and J. Lau
Large Trials vs Meta-analysis of Smaller Trials: How Do Their Results Compare?
JAMA, October 23, 1996; 276(16): 1332 - 1338.
[Abstract] [PDF]


Home page
JAMAHome page
G. T. Jeng, J. R. Scott, and L. F. Burmeister
A Comparison of Meta-analytic Results Using Literature vs Individual Patient Data: Paternal Cell Immunization for Recurrent Miscarriage
JAMA, September 13, 1995; 274(10): 830 - 836.
[Abstract] [PDF]



Advertisement